Patients presented predominantly breast cancer submitted to surgery (17 patients [77%] in the experimental arm and 19 [86%] patients in the control arm) with HER2-negative phenotype (15 patients [68%] in the experimental arm and 12 [55%] patients in the control arm). The gene discussed is ERBB2; the disease is breast carcinoma.